U.S. GAAP basis $ 25,809 $ 35,637 Adjustments: Revenue related to noncontrolling interests 9,523 Interest expense on long-term... | May 4, 2023
Stay updated with breaking news from Intangible Assets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. GAAP basis $ 25,809 $ 35,637 Adjustments: Revenue related to noncontrolling interests 9,523 Interest expense on long-term... | May 4, 2023
Post IFRS 16 39.7% % of Net Revenue - Post IFRS 16 ... | May 4, 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology
- Reiterates Full Year 2023 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology
Net sales in the third quarter of fiscal 2023 totaled $484.7 million, an all-time quarterly high and up 32% year-over-year; foreign currency had a 2% unfavorable impact on net sales compared to the... | May 4, 2023